Tag: LVO
SNIS 2022: Research shows AI-based stroke diagnostics can expand access to...
A new study presented at the Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) shows that artificial intelligence (AI) technology...
Rare disease variant specific to East Asian patients increases post-EVT reocclusion...
Among people who received endovascular mechanical thrombectomy to remove a large vessel occlusion (LVO), those with a rare genetic disease variant found primarily in people...
Alarming trends and alarmist myths: What is the link between COVID-19...
Over the course of the past two years, the accepted understanding of how COVID-19 spreads and functions has improved vastly, with preventative vaccines and...
New player in stent retriever space demonstrates non-inferiority to Solitaire device
A relatively new introduction to the field of endovascular therapy (EVT) for acute ischaemic stroke, the Skyflow stent retriever (Skyflow), has demonstrated non-inferiority with...
Newer clot-busting medication may someday increase time window for stroke treatment
In a phase 2a clinical trial in China, the clot-busting medication tenecteplase has been shown to be effective in restoring blood flow to the...
Reducing disability and death: What is next for stroke triage and...
Michael Chen (Rush University Medical Center, Chicago, USA) discusses the growing awareness around the need for timely interventions in stroke care in the USA,...
Phenox expands acute ischaemic stroke portfolio with global launch of pRESET...
Phenox has added to its extensive technology portfolio with the introduction of the pRESET 6-50 mechanical thrombectomy device for the treatment of acute large...
Direct mechanical thrombectomy fails to show non-inferiority compared with IV t-PA...
The preliminary results of the SWIFT-DIRECT (Solitaire with the intention for thrombectomy plus IV t-PA versus direct Solitaire stent-retriever thrombectomy in acute anterior circulation...
Gender disparity in comprehensive stroke centre routing highlighted at SNIS
Women may be less likely than men to be sent to a comprehensive, or “Level 1”, stroke centre for emergent large vessel occlusion (ELVO)...
Viz.ai receives CE mark to bring AI-powered stroke care software to...
Viz.ai has been awarded a CE mark for its artificial intelligence (AI)-powered stroke care software, affirming its conformity with European health, safety and environmental...
Higher incidence of severe stroke found in COVID-19 patients
Among people who have strokes and COVID-19, there is a higher incidence of severe stroke as well as a higher incidence of stroke in...
First patient enrolled in MindRhythm trial to assess LVO stroke diagnostic...
MindRhythm, a US medical technology company focused on preventing neurological injury in stroke, has announced the enrolment of the first patient in a multicentre...
RapidAI announces software approval for Medicare New Technology Add-on Payment
RapidAI states Rapid LVO is among the first software products to qualify for the New Technology Add-on Payment (NTAP).
NTAP is part of the CMS...
RapidAI receives FDA clearance of Rapid LVO for identification of suspected...
RapidAI has announced that Rapid LVO has received US Food and Drug Administration (FDA) clearance for detecting suspected large vessel occlusions (LVOs).
Rapid LVO helps...
Viz.ai adds new capabilities to its AI stroke platform
Viz.ai has launched the next generation of its synchronized care platform for stroke. Viz.ai incorporates cutting edge artificial intelligence with HIPAA-compliant communication to allow...
US FDA clears Aidoc’s complete AI stroke package
Aidoc has announced that the US Food and Drug Administration (FDA) has cleared its AI solution for flagging large vessel occlusion (LVO) in head...
Medtronic gets US FDA clearance for Riptide aspiration system
The Riptide aspiration system is intended for use in the revascularisation of patients with acute ischaemic stroke secondary to intracranial large vessel occlusive disease...
